{"id":15575,"date":"2022-01-05T13:00:25","date_gmt":"2022-01-05T13:00:25","guid":{"rendered":"https:\/\/staging.rayner.com\/blog\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/"},"modified":"2024-11-11T15:37:11","modified_gmt":"2024-11-11T15:37:11","slug":"rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol","status":"publish","type":"post","link":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/","title":{"rendered":"Rayner expands RayOne portfolio with first blue light filtering IOL"},"content":{"rendered":"

JANUARY 05, 2022<\/strong>\u00a0\u2013 Worthing, United Kingdom.\u00a0Rayner, the only UK manufacturer of intraocular lenses (IOLs)<\/a>, today announced the launch of RayOne Hydrophobic BLF. Made of its proprietary ultra glistening-free hydrophobic material, RayOne Hydrophobic BLF is Rayner\u2019s first blue light filtering IOL.<\/span><\/p>\n

RayOne Hydrophobic BLF expands Rayner\u2019s RayOne lens portfolio from seven to eight variants, now with an option for surgeons who wish to offer patients a blue light filtering IOL that could help to protect the retina from potentially harmful blue light and may be useful in reducing the risk of Age-related Macular Degeneration (AMD) in pseudophakic eyes.<\/span><\/p>\n

Rayner CEO, Tim Clover, said of the launch: \u201cOver a third of all lenses implanted have blue light filtering properties so we are thrilled to supplement our RayOne Hydrophobic solution with the new BLF variant, and offer surgeons the choice between clear and yellow IOL options.\u201d<\/span><\/p>\n

Packaged in Rayner<\/a>\u2019s award-winning fully preloaded injector system, RayOne Hydrophobic BLF benefits from the same aspheric aberration-neutral optic design and patented Cornerstone tabs as the clear variant, which combine with anti-vaulting haptic technology to create superb stability once inside the capsular bag. Rayner\u2019s hydrophobic material is not dependent on the temperature within the operating theatre, so it arrives ready-to-use with no warming or waiting needed for an efficient surgical procedure.<\/span><\/p>\n

Unlike some blue light filtering IOLs, RayOne<\/a> Hydrophobic BLF does not block all blue light, a small amount is still transmitted through the lens to stimulate the natural circadian rhythm for a healthy sleep-wake cycle.<\/span><\/p>\n

Dr. Till C. Werner, ophthalmic surgeon at Dr. Werner & Kollegen in Germany, implanted the world\u2019s first RayOne Hydrophobic BLF on 2<\/span>nd<\/span> November 2021 as part of the pre-launch evaluation, and commented: \u201cI was honoured to implant the very first RayOne Hydrophobic BLF blue light filter IOL from Rayner. The hydrophobic lens ejected predictably from the preloaded injector and unfolded very smoothly inside the eye.\u201d<\/span><\/p>\n

RayOne Hydrophobic BLF is now commercially available from 0.0 D to +32.0 D in CE certificate-accepting countries.<\/span><\/p>\n

Read more about Rayner’s BLF<\/a>.\u00a0<\/span><\/p>\n

END<\/span><\/p>\n

 <\/p>\n

About Rayner<\/strong><\/p>\n

Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley 1949, Rayner has continuously pioneered intraocular lens (IOL) design with a goal to improve vision and restore sight worldwide. Today, Rayner\u2019s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.\u202f<\/span>\u00a0<\/span><\/p>\n

Headquartered in Worthing, United Kingdom, Rayner markets its IOL, OVD, dry eye and digital health portfolio worldwide in over 80 countries through a network of distributors, with direct sales teams in the United Kingdom, USA, Germany, Austria, Switzerland, Italy, India<\/span>,\u202f<\/span>Spain and Portugal<\/span>.\u202f<\/span>\u00a0<\/span><\/p>\n

To support Rayner\u2019s international growth, CVC Capital Partners VIII acquired a majority interest in the company in June 2021. Established in 1981 and with international reach and experience of the healthcare sector, CVC is a world leader in private equity and credit with $125 billion of assets under management and $165\u202fbillion\u202fof funds committed.\u202f<\/span><\/p>\n

For\u00a0further information and media enquiries, please contact Rayner: marketingteam@rayner.com<\/a><\/span>\u00a0<\/strong><\/p>\n

EC 2021-85 01\/22<\/span><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

JANUARY 05, 2022\u00a0\u2013 Worthing, United Kingdom.\u00a0Rayner, the only UK manufacturer of intraocular lenses (IOLs), today announced the launch of RayOne Hydrophobic BLF. Made of its proprietary ultra glistening-free hydrophobic material, RayOne Hydrophobic BLF is Rayner\u2019s first blue light filtering IOL. RayOne Hydrophobic BLF expands Rayner\u2019s RayOne lens portfolio from seven to eight variants, now with<\/p>\n","protected":false},"author":300,"featured_media":14328,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[942,946,945,948],"tags":[],"acf":[],"yoast_head":"\nRayner Adds Blue Light IOL | Rayner Global<\/title>\n<meta name=\"description\" content=\"Rayner expands the RayOne IOL portfolio with its blue light-filtering IOL for superior visual outcomes post-cataract surgery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rayner Adds Blue Light IOL | Rayner Global\" \/>\n<meta property=\"og:description\" content=\"Rayner expands the RayOne IOL portfolio with its blue light-filtering IOL for superior visual outcomes post-cataract surgery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/\" \/>\n<meta property=\"og:site_name\" content=\"Rayner : Brazil\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-05T13:00:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-11T15:37:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"837\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"amber\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"amber\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/\",\"url\":\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/\",\"name\":\"Rayner Adds Blue Light IOL | Rayner Global\",\"isPartOf\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg\",\"datePublished\":\"2022-01-05T13:00:25+00:00\",\"dateModified\":\"2024-11-11T15:37:11+00:00\",\"author\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf\"},\"description\":\"Rayner expands the RayOne IOL portfolio with its blue light-filtering IOL for superior visual outcomes post-cataract surgery.\",\"breadcrumb\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#primaryimage\",\"url\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg\",\"contentUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg\",\"width\":837,\"height\":673},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/rayner.com\/br-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rayner expands RayOne portfolio with first blue light filtering IOL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\",\"url\":\"https:\/\/rayner.com\/br-pt\/\",\"name\":\"Rayner : Brazil\",\"description\":\"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rayner.com\/br-pt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf\",\"name\":\"amber\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g\",\"caption\":\"amber\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rayner Adds Blue Light IOL | Rayner Global","description":"Rayner expands the RayOne IOL portfolio with its blue light-filtering IOL for superior visual outcomes post-cataract surgery.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/","og_locale":"en_GB","og_type":"article","og_title":"Rayner Adds Blue Light IOL | Rayner Global","og_description":"Rayner expands the RayOne IOL portfolio with its blue light-filtering IOL for superior visual outcomes post-cataract surgery.","og_url":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/","og_site_name":"Rayner : Brazil","article_published_time":"2022-01-05T13:00:25+00:00","article_modified_time":"2024-11-11T15:37:11+00:00","og_image":[{"width":837,"height":673,"url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg","type":"image\/jpeg"}],"author":"amber","twitter_card":"summary_large_image","twitter_misc":{"Written by":"amber","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/","url":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/","name":"Rayner Adds Blue Light IOL | Rayner Global","isPartOf":{"@id":"https:\/\/rayner.com\/br-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#primaryimage"},"image":{"@id":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#primaryimage"},"thumbnailUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg","datePublished":"2022-01-05T13:00:25+00:00","dateModified":"2024-11-11T15:37:11+00:00","author":{"@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf"},"description":"Rayner expands the RayOne IOL portfolio with its blue light-filtering IOL for superior visual outcomes post-cataract surgery.","breadcrumb":{"@id":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#primaryimage","url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg","contentUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/Dr.-Till-C.-Werner.jpg","width":837,"height":673},{"@type":"BreadcrumbList","@id":"https:\/\/rayner.com\/br-pt\/rayner-expands-rayone-portfolio-with-first-blue-light-filtering-iol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rayner.com\/br-pt\/"},{"@type":"ListItem","position":2,"name":"Rayner expands RayOne portfolio with first blue light filtering IOL"}]},{"@type":"WebSite","@id":"https:\/\/rayner.com\/br-pt\/#website","url":"https:\/\/rayner.com\/br-pt\/","name":"Rayner : Brazil","description":"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rayner.com\/br-pt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf","name":"amber","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g","caption":"amber"}}]}},"_links":{"self":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15575"}],"collection":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/users\/300"}],"replies":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/comments?post=15575"}],"version-history":[{"count":6,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15575\/revisions"}],"predecessor-version":[{"id":24183,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15575\/revisions\/24183"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media\/14328"}],"wp:attachment":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media?parent=15575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/categories?post=15575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/tags?post=15575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}